Qube Research & Technologies (QRT)
GMAB icon

Qube Research & Technologies (QRT)’s Genmab GMAB Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$46.4M Buy
1,689,284
+1,011,938
+149% +$26.9M 0.04% 521
2026
Q1 		$18.2M Buy
677,346
+637,891
+1,617% +$19.1M 0.02% 925
2025
Q4 		$1.22M Buy
+39,455
New +$1.23M ﹤0.01% 2475
2025
Q2 		– Sell
-111,156
Closed -$2.18M – 3698
2025
Q1 		$2.18M Sell
111,156
-125,680
-53% -$2.64M ﹤0.01% 1918
2024
Q4 		$4.94M Sell
236,836
-76,709
-24% -$1.69M 0.01% 1505
2024
Q3 		$7.64M Buy
313,545
+199,022
+174% +$5.32M 0.01% 1191
2024
Q2 		$2.88M Sell
114,523
-123,433
-52% -$3.5M ﹤0.01% 1477
2024
Q1 		$7.12M Sell
237,956
-19,160
-7% -$563K 0.01% 1028
2023
Q4 		$8.19M Buy
257,116
+127,109
+98% +$3.99M 0.02% 814
2023
Q3 		$4.59M Sell
130,007
-99,442
-43% -$3.79M 0.01% 975
2023
Q2 		$8.72M Sell
229,449
-43,954
-16% -$1.75M 0.03% 572
2023
Q1 		$10.3M Sell
273,403
-115,678
-30% -$4.45M 0.04% 463
2022
Q4 		$16.5M Buy
+389,081
New +$16M 0.09% 328
2022
Q2 		– Sell
-23,198
Closed -$839K – 2734
2022
Q1 		$839K Sell
23,198
-16,086
-41% -$552K 0.01% 1254
2021
Q4 		$1.55M Buy
39,284
+24,583
+167% +$1.03M 0.01% 950
2021
Q3 		$642K Sell
14,701
-8,614
-37% -$387K 0.01% 1095
2021
Q2 		$952K Buy
+23,315
New +$900K 0.01% 965
2021
Q1 		– Sell
-30,383
Closed -$1.24M – 2107
2020
Q4 		$1.24M Buy
30,383
+12,459
+70% +$466K 0.02% 795
2020
Q3 		$656K Buy
+17,924
New +$648K 0.01% 939

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Qube Research & Technologies (QRT)'s GMAB Position: Q2 2026 in Review

Qube Research & Technologies (QRT) increased its Genmab (GMAB) stake by 149% in Q2 2026, buying an estimated $26.9M and bringing the position to 1,689,284 shares worth $46.4M. The position accounts for 0.04% of the portfolio, ranked #521.

Qube Research & Technologies (QRT) first reported a position in GMAB in Q3 2020 and has held it in 19 quarters since. 292 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Qube Research & Technologies (QRT) held 1,689,284 shares of Genmab worth $46.4M as of Q2 2026.
  • Qube Research & Technologies (QRT) bought 1,011,938 Genmab shares in Q2 2026, an estimated $26.9M.
  • Genmab made up 0.04% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #521 holding.
  • Qube Research & Technologies (QRT) first reported a position in Genmab in Q3 2020 and has held it in 19 quarters since.
  • 292 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.